Short Interest in Exicure, Inc. (NASDAQ:XCUR) Declines By 34.8%

Exicure, Inc. (NASDAQ:XCUR) was the recipient of a significant drop in short interest during the month of December. As of December 15th, there was short interest totalling 61,200 shares, a drop of 34.8% from the November 30th total of 93,900 shares. Based on an average daily trading volume, of 725,400 shares, the days-to-cover ratio is currently 0.1 days. Currently, 5.6% of the shares of the company are short sold.

Exicure Trading Up 1.9 %

Shares of XCUR stock opened at $17.58 on Friday. Exicure has a twelve month low of $1.44 and a twelve month high of $36.00. The business’s 50 day moving average is $12.57 and its two-hundred day moving average is $5.19. The company has a market capitalization of $45.81 million, a P/E ratio of -8.49 and a beta of 3.66.

About Exicure

Exicure, Inc, an early-stage biotechnology company, develops nucleic acid therapies targeting ribonucleic acid against validated targets. The company's preclinical candidate includes SCN9A that is in preclinical studies for the treatment of chronic pain. It also develops immuno-oncology therapeutics based on its proprietary SNA technology.